Search research articles
Contact Us
Filters
Showing results (51-60 of 236) with videos related to
Page
of 24
Sort By:
American Journal of Medical Genetics
|
June 5, 1995
Significance of lipopigments with fingerprint profiles in eccrine sweat gland epithelial cells
H H Goebel, I Warlo, T Klockgether, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 1, 1986
The rat ventromedial thalamic nucleus and motor control: role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission
T Klockgether, M Schwarz, L Turski, et al.
Experimental Brain Research
|
January 1, 1988
Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex
T Klockgether, M Schwarz, L Turski, et al.
Brain Research
|
December 3, 1986
Motor actions of excitatory amino acids and their antagonists within the rat ventromedial thalamic nucleus
T Klockgether, L Turski, M Schwarz, et al.
Neuroscience Letters
|
May 18, 1990
Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice
L Turski, K Bressler, T Klockgether, et al.
Brain Research
|
August 6, 1986
Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine
L Turski, M Schwarz, T Klockgether, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section
|
January 1, 1993
The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist
T Klockgether, P Jacobsen, P A Löschmann, et al.
Brain Research
|
September 29, 1987
Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate
U Wüllner, T Klockgether, M Schwarz, et al.
Der Nervenarzt
|
July 27, 2011
[The presymptomatic stage of neurodegenerative disorders]
C Klein, J Hagenah, B Landwehrmeyer, et al.
Lancet (London, England)
|
September 21, 1996
Repeat length and disease progression in spinocerebellar ataxia type 3
T Klockgether, B Kramer, R Lüdtke, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 236) with videos related to
Sort By:
Page
of 24
American Journal of Medical Genetics
|
June 5, 1995
Significance of lipopigments with fingerprint profiles in eccrine sweat gland epithelial cells
H H Goebel, I Warlo, T Klockgether, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 1, 1986
The rat ventromedial thalamic nucleus and motor control: role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission
T Klockgether, M Schwarz, L Turski, et al.
Experimental Brain Research
|
January 1, 1988
Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex
T Klockgether, M Schwarz, L Turski, et al.
Brain Research
|
December 3, 1986
Motor actions of excitatory amino acids and their antagonists within the rat ventromedial thalamic nucleus
T Klockgether, L Turski, M Schwarz, et al.
Neuroscience Letters
|
May 18, 1990
Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice
L Turski, K Bressler, T Klockgether, et al.
Brain Research
|
August 6, 1986
Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine
L Turski, M Schwarz, T Klockgether, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section
|
January 1, 1993
The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist
T Klockgether, P Jacobsen, P A Löschmann, et al.
Brain Research
|
September 29, 1987
Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate
U Wüllner, T Klockgether, M Schwarz, et al.
Der Nervenarzt
|
July 27, 2011
[The presymptomatic stage of neurodegenerative disorders]
C Klein, J Hagenah, B Landwehrmeyer, et al.
Lancet (London, England)
|
September 21, 1996
Repeat length and disease progression in spinocerebellar ataxia type 3
T Klockgether, B Kramer, R Lüdtke, et al.
Page
of 24